# Tymlos (abaloparatide): Dosage, Side Effects & Uses

Source: https://pepvault.app/drugs/tymlos

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Brand-name drugs](https://pepvault.app/drugs) Tymlos

Brand-name drug · parathyroid hormone-related peptide analog (PTHrP 1-34)

# Tymlos (abaloparatide)

From the FDA label, read Nov 18, 2026 [Published by PepVault](https://pepvault.app/guides/how-we-research)

Tymlos is abaloparatide from Radius Health, a lab-made copy of the first 34 building blocks of a protein related to parathyroid hormone, given as one shot a day from a pen to build new bone.

FDA approved it for women after menopause with osteoporosis at high risk of fracture, in whom it lowers the risk of spine and other fractures, and to increase bone density in men with osteoporosis at high risk of fracture.

- **Active ingredient:** [Abaloparatide](https://pepvault.app/peptides/abaloparatide)
- **Maker:** Radius Health
- **Class:** parathyroid hormone-related peptide analog (PTHrP 1-34)
- **FDA application:** [NDA 208743](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208743), first approved 2017

## What FDA approved it for

On the label, high risk means a past fracture from weak bones or several risk factors for one, or that other osteoporosis treatment failed or could not be tolerated.

The course has a firm limit: Tymlos was not studied beyond 2 years, and the label does not recommend more than 2 years of it in a lifetime.

From the label: 12.1 Mechanism of Action; 1 Indications and Usage; 2.3 Treatment Duration.

## How it is supplied

Tymlos’s forms and the doses each one gives, as the label lists them

| Form | Doses |
| --- | --- |
| Prefilled pen (30 daily doses) | 80 mcg |

From the label: 3 Dosage Forms and Strengths.

## The label’s dosing schedule

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

### Tymlos, once a day

Tymlos, once a day: one dose on the label, 80 mcg.

| Dose | When, on the label |
| --- | --- |
| 80 mcg a day | Every day, at about the same time |

There is no climb: every dose is 80 mcg, and one pen holds 30 of them.

From the label: 2.1 Recommended Dosage.

## How it’s taken

Tymlos goes under the skin of the belly around the navel, at about the same time each day, moving to a new spot daily. It is never given into a vein or muscle.

For the first several doses, the shot is given where the person can sit or lie down, since blood pressure can drop on standing within 4 hours, with dizziness, a racing heart or nausea that eases on lying down.

The label adds calcium and vitamin D when the diet falls short. Needles are not in the box.

From the label: 2.2 Administration Instructions; 5.3 Orthostatic Hypotension; 2.1 Recommended Dosage.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## If a dose is missed

Tymlos’s label gives no instruction for a missed dose; a prescriber or pharmacist can answer for a given case.

## Storage

Before its first use, a Tymlos pen stays in the fridge at 36°F to 46°F. After the first dose it is kept at room temperature, 68°F to 77°F, for up to 30 days. It is never frozen or left in heat.

From the label: 16.2 Storage and Handling.

## Side effects and warnings

Adverse reactions in at least 2% of women on Tymlos and more often than on placebo, the 18-month trial in women after menopause with osteoporosis. Percent of people.

| Reaction | Placebo | 80 mcg |
| --- | --- | --- |
| Calcium in the urine (hypercalciuria) | 9 | 11 |
| Dizziness | 6 | 10 |
| Nausea | 3 | 8 |
| Headache | 6 | 8 |
| Pounding or fast heartbeat (palpitations) | 0.4 | 5 |
| Tiredness | 2 | 3 |
| Upper belly pain | 2 | 3 |
| Vertigo | 2 | 2 |

Reactions where the shot goes in were common in the first month: redness in 58% against 28% on placebo, swelling in 11% against 3%, and pain in 10% against 7%.

In the trial, 10% stopped Tymlos because of side effects against 6% on placebo, most often for nausea, dizziness, headache or palpitations.

### The other warnings

Tymlos has no boxed warning. Its warnings cover allergic reactions; osteosarcoma, a bone cancer that abaloparatide caused in rats at 4 to 28 times the human exposure (whether it does in people is unknown), so it is avoided in people already at higher risk of it; dizziness on standing; high blood calcium; and calcium in the urine and kidney stones.

From the label: 6.1 Clinical Trials Experience; 5 Warnings and Precautions.

## What else we have on abaloparatide

### Abaloparatide on PepVault

- [Abaloparatide in the peptide library](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide: half-life](https://pepvault.app/peptides/abaloparatide/half-life)
- [Abaloparatide: side effects](https://pepvault.app/peptides/abaloparatide/side-effects)
- [Abaloparatide: how long it takes to work](https://pepvault.app/peptides/abaloparatide/how-long-to-work)
- [Is Abaloparatide legal? FDA, DEA and WADA status](https://pepvault.app/peptides/abaloparatide/legal-status)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Free tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Abaloparatide: fewer new vertebral fractures vs placebo in ACTIVE](https://pepvault.app/research/abaloparatide-active-2016)
- [Abaloparatide then alendronate: 84% lower vertebral fracture risk](https://pepvault.app/research/abaloparatide-activextend-2018)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)

### Brand against brand

- [Forteo vs Tymlos](https://pepvault.app/drugs/compare/forteo-vs-tymlos)

### Compound against compound

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

## Questions about Tymlos

### What is the dose of Tymlos?

The label’s dose is 80 mcg injected under the skin of the belly once a day, at about the same time each day. A prescriber decides whether it fits.

### How long can Tymlos be used?

The label does not recommend more than 2 years of Tymlos in a lifetime; it was not studied for longer.

### Does Tymlos need to be refrigerated?

Only before the first dose, at 36°F to 46°F. After that, the pen is kept at room temperature, 68°F to 77°F, for up to 30 days.

### What is the most common side effect of Tymlos?

Redness where the shot goes in, in 58% of women in the first month against 28% on placebo. Nausea and dizziness were the side effects that most often led people to stop.

### Is Tymlos approved for men?

Yes. Its label adds men with osteoporosis at high risk of fracture, to increase bone density.

## Sources

- [TYMLOS (abaloparatide) injection, for subcutaneous use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=712143d9-e21e-4013-bb3b-3426a21060a8) (version 19, published Aug 17, 2026; read Nov 18, 2026)
- [Drugs@FDA, NDA 208743](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208743) (Tymlos, the pen; application first approved 2017)

PepVault is not affiliated with Radius Health. Tymlos is a trademark of its owner.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on abaloparatide

### Abaloparatide on PepVault

- [Abaloparatide in the peptide library](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide: half-life](https://pepvault.app/peptides/abaloparatide/half-life)
- [Abaloparatide: side effects](https://pepvault.app/peptides/abaloparatide/side-effects)
- [Abaloparatide: how long it takes to work](https://pepvault.app/peptides/abaloparatide/how-long-to-work)
- [Is Abaloparatide legal? FDA, DEA and WADA status](https://pepvault.app/peptides/abaloparatide/legal-status)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Free tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Abaloparatide: fewer new vertebral fractures vs placebo in ACTIVE](https://pepvault.app/research/abaloparatide-active-2016)
- [Abaloparatide then alendronate: 84% lower vertebral fracture risk](https://pepvault.app/research/abaloparatide-activextend-2018)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Brand-name drugs

- [Every brand, by ingredient](https://pepvault.app/drugs)
- [Forteo vs Tymlos](https://pepvault.app/drugs/compare/forteo-vs-tymlos)

## The library

- [Abaloparatide in the peptide library](https://pepvault.app/peptides/abaloparatide)
- [The peptide reference library](https://pepvault.app/peptides)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. PepVault is not affiliated with Radius Health. Tymlos is a trademark of its owner.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
